We are happy to announce that our long-term client and trusted partner, Greene Street Pharmaceuticals LLC, strengthened our business relationship today by appointing us as their exclusive API sourcing partner.

The Pennsylvania-based company specializes in #transdermal delivery systems with the vision to make a meaningful impact on patients’ lives. Greene Street utilizes Quinta-Analytica’s API Solution services for multiple projects and is able to leverage the partnership to ensure a high level of continuity and expand their offering beyond the scope of their core service provision.

This is yet another recognition of Quinta’s world-class API Solutions program, which supports partners from all geographies and backgrounds with our robust services – now and into the future!

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.